This inventor holds 1 USPTO granted patent. Top assignee: The Green Cross Corporation. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Kazumi Fukuyama: Innovator in Monoclonal Antibody Research
Introduction
Kazumi Fukuyama is a notable inventor based in Kyoto, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work is crucial for advancements in cancer detection and treatment.
Latest Patents
Kazumi Fukuyama holds a patent for a monoclonal antibody, which is described as having specific reactivity with cancer-associated antigens. These antigens include those associated with pancreas cancer, intestinum crassum cancer, and hepatoma. The patent outlines a process for preparing the antibody and a reagent for detecting it. This innovation is vital for improving cancer diagnostics.
Career Highlights
Fukuyama is affiliated with The Green Cross Corporation, where she continues her research and development efforts. Her work has positioned her as a key figure in the biotechnology sector, contributing to the understanding and treatment of various cancers.
Collaborations
Kazumi has collaborated with esteemed colleagues, including Eiji Kashiwagi and Kazuaki Nakura. These partnerships have enhanced her research capabilities and broadened the impact of her innovations.
Conclusion
Kazumi Fukuyama's contributions to monoclonal antibody research exemplify her dedication to advancing medical science. Her innovative work continues to pave the way for improved cancer detection and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile